Structure-guided analysis of the human APOBEC3-HIV restrictome
- PMID: 24657093
- DOI: 10.1016/j.str.2014.02.011
Structure-guided analysis of the human APOBEC3-HIV restrictome
Abstract
Human APOBEC3 (A3) proteins are host-encoded intrinsic restriction factors that inhibit the replication of many retroviral pathogens. Restriction is believed to occur as a result of the DNA cytosine deaminase activity of the A3 proteins; this activity converts cytosines into uracils in single-stranded DNA retroviral replication intermediates. A3 proteins are also equipped with deamination-independent means to restrict retroviruses that work cooperatively with deamination-dependent restriction pathways. A3 proteins substantially bolster the intrinsic immune system by providing a powerful block to the transmission of retroviral pathogens; however, most retroviruses are able to subvert this replicative restriction in their natural host. HIV-1, for instance, evades A3 proteins through the activity of its accessory protein Vif. Here, we summarize data from recent A3 structural and functional studies to provide perspectives into the interactions between cellular A3 proteins and HIV-1 macromolecules throughout the viral replication cycle.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions.Protein Sci. 2020 Feb;29(2):391-406. doi: 10.1002/pro.3729. Epub 2019 Nov 29. Protein Sci. 2020. PMID: 31518043 Free PMC article. Review.
-
Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F.Nat Commun. 2013;4:2593. doi: 10.1038/ncomms3593. Nat Commun. 2013. PMID: 24185281 Free PMC article.
-
Enhancing the Catalytic Deamination Activity of APOBEC3C Is Insufficient to Inhibit Vif-Deficient HIV-1.J Mol Biol. 2017 Apr 21;429(8):1171-1191. doi: 10.1016/j.jmb.2017.03.015. Epub 2017 Mar 16. J Mol Biol. 2017. PMID: 28315663
-
A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent Degradation.Trends Mol Med. 2018 May;24(5):507-520. doi: 10.1016/j.molmed.2018.03.004. Epub 2018 Mar 30. Trends Mol Med. 2018. PMID: 29609878 Free PMC article. Review.
-
APOBEC3 proteins and reverse transcription.Virus Res. 2008 Jun;134(1-2):74-85. doi: 10.1016/j.virusres.2007.12.022. Epub 2008 Feb 11. Virus Res. 2008. PMID: 18262674 Review.
Cited by
-
Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis.Bioengineered. 2021 Dec;12(1):2074-2086. doi: 10.1080/21655979.2021.1931640. Bioengineered. 2021. PMID: 34043485 Free PMC article. Review.
-
Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions.Protein Sci. 2020 Feb;29(2):391-406. doi: 10.1002/pro.3729. Epub 2019 Nov 29. Protein Sci. 2020. PMID: 31518043 Free PMC article. Review.
-
Structural Insights into APOBEC3-Mediated Lentiviral Restriction.Viruses. 2020 May 27;12(6):587. doi: 10.3390/v12060587. Viruses. 2020. PMID: 32471198 Free PMC article. Review.
-
Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA.Nat Commun. 2018 Jun 25;9(1):2460. doi: 10.1038/s41467-018-04872-8. Nat Commun. 2018. PMID: 29941968 Free PMC article.
-
Characterization of the Catalytic Domain of Human APOBEC3B and the Critical Structural Role for a Conserved Methionine.J Mol Biol. 2015 Sep 25;427(19):3042-55. doi: 10.1016/j.jmb.2015.08.006. Epub 2015 Aug 14. J Mol Biol. 2015. PMID: 26281709 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
